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HEALTH POLICY GOVERNANCE IN THE EU: 
COMPOSING A JIGSAW PUZZLE? 
 
 
 
Cristinela-Ionela VELICU* 
 
 
Abstract. This paper aims to analyze the impact of the economic and the political 
integration and also the Europeanisation on health policies and health systems in the EU. How 
European Union objectives can affect policies places under exclusively national competence? Health 
policy appears to be an enclave within the European integration, because health is perceived as an area 
with firm member state control, with a minimal EU role in the incremental and irresistible process of 
harmonization and Europeanisation.  Although, health systems in the EU share common values and 
different health priorities and backgrounds the question that arises is : can we talk about market 
integration of health policies? I argue that the impact of European integration on national healthcare 
and the ways in which governments adjust their institutionalized healthcare governance do it – in terms 
of regulation of access, funding, membership entitlements, and management can be an interesting 
analysis of the evolution of health care systems and policies in the European Union. 
 
Keywords: Health policy, Europeanisation, EU, Governance, European single health 
market 
 
 
1. European Union: a Particular System of Governance 
 
1.1. Introduction  
 How do European Union legislation and policies affect the health 
sector? This question seems to be paradoxical since, at first glance, there is no 
such thing as a common European health policy. This paper argues that health 
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policy is a good example to demonstrate the impact of Europeanisation of 
healthcare market.  EU health policy is a relatively new policy area with a 
distinctive history (Abel-Smith, 1995; Geyer, 2000; Greer 2005) Influenced by 
the 1996 bovine spongiform encephalopathy (BSE) crisis in the United 
Kingdom and a blood contamination crisis in France (Coleman, 2004), health 
became a major issue at the European level in the run up to the Amsterdam 
treaty negotiations.  In consequence, Article 152 of the 1997 Amsterdam Treaty 
laid the foundation for mainstreaming health policy in stating that: “a high level 
of human health protection shall be ensured in the definition and 
implementation of all Community policies and activities.”  In 1999 the Prodi 
Commission created the new DG Health and Consumer Protection (DG 
SANCO).  In 2000, health policies were integrated into the Lisbon Strategy for 
Jobs and Growth and health programmes were financed trough EU public 
health action programmes.  
 
 
1.2 EU Governance  
 Governance is a system of rules, norms, and institutions that govern 
public and private behavior across national boundaries (UN Commission on 
Global Governance, 1995), and it occurs at different levels within the 
international system (Krahman, 2003). Scholars had divided the 
compartmentalized governance structure within the EU into three levels, 
depending on whether Member States had federal or unitary domestic political 
structures (Hooghe and Marks, 2001; Marks, 1993). The relationships between 
these levels of governance are complex and amorphous as local 
units/governments have been venues for policy innovation as well (Cairney, 
2007).  The literature on governance, in particular that applied to the European 
Union, it is predominantly descriptive and normative, and rarely rigorously 
analytical (Pierre, Peters, 2005). From the point of view of the actors involved, 
governance is a means for achieving goals. It promises to guarantee the 
effectiveness of policy implementation not assured by mere coercion (Héritier, 
2002/ 2003). Governance is therefore a system of coproduction of norms and 
public goods where the co-producers are different kinds of actors (Bartolini, 
2011: 8). 
 Multilevel governance in the EU refers to how EU institutions, the 
Member States, and the interaction between substate entities. International 
relations theories such as institutionalism, which emphasizes cooperation 
through common interests (Keohane, Martin 1995; Pollack, 1996), or critical 
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theory, which emphasizes cooperation through norms (Wendt, 1992), do not 
explain how established institutions incrementally share authority with their 
constituent Member States. The venue-shifting approach to policymaking, 
where policy entrepreneurs try to move decision making to favorable 
institutions for their goals (Baumgartner, Jones 1993; Leibfried, Pierson, 1995) 
cannot explain how the EU has gained authority in health policies, because EU 
states and substate entities have been prominent venues for national health 
programmes.  Sovereignty has been conceptualized in three major ways: (1) 
international legal sovereignty, (2) Westphalian sovereignty, and (3) domestic 
sovereignty (Krasner, 2005; Lake, 2003). Health public policies are governed in 
terms of “shared soveranity”. “Shared sovereignty” involves the engagement of 
external actors in some of the domestic authority structures of states for an 
indefinite period of time (Jamison, Frenk and Knaul, 1998; Krasner, 2005; 
Lake, 2003). According to Stephen Krasner (2005), shared-sovereignty 
institutions require three pre-conditions: (1) there must be international 
sovereignty, (2) the agreement must be voluntary, and (3) the arrangement must 
not ask the third party to contribute large resources. Under this arrangement, 
state actors have the authority to enter into agreements that would compromise 
their Westphalian sovereignty, with the goal of improving domestic sovereignty. 
While states preserve their authority to enter voluntary agreements, they cede 
their autonomy by pooling their resources into a multilateral organization or 
their commitments into an international treaty, which then become vehicles for 
international collective action (Jamison, Frenk and Knaul, 1998). Krasner 
argues that shared sovereignty could be limited to specific issue areas. States 
become bound by adherence to international norms developed as a result of 
this collective action or cooperation. In this respect, the state does not have the 
sole authority over policy but is disaggregated, composed of state officials, 
nongovernmental organizations (NGOs), judges, commissions, and concerned 
citizens coming together to foment change (Vaughan and Kilcommins, 2007). 
Phenomena such as globalization, interdependence, and regional integration 
have diminished the ability of states to be self-reliant, and as a result 
international institutions have emerged to deal with many issues that transcend 
national boundaries, leading to shared sovereignty.  European governance is 
not just determined by the structural properties of the European Community 
system but also influenced by actor’s perceptions of legitimate organising 
principles. (Kohler-Koch, 2005: 15) To understand the main characteristics of 
the European social policy governance it is important to analyse the original 
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procedural patterns under the EEC Treaty. The social chapter of the 1957 EEC 
Treaty (EECT) was based on national competence and on hierarchical relations 
between public and private actors, the Member States had almost exclusive 
competence in this area. The Commission was assigned “the task of promoting 
close co-operation” between Member States (Art. 118 EECT). 
 The EU legitimacy to act is stated in the Treaty on the European Union 
but it faces two major challenges: 1) the multitude and diversity of actors (at 
national and global level, different government departments, different 
organisations, different sectors, public/private, etc. and 2) different Member 
States health agendas (security, economic, political, social justice, soft 
power/philanthropy). The EU has a Treaty obligation in Art. 168 to “foster 
cooperation with third countries and the competent international organizations 
in the sphere of public health”, with a particular emphasis on the regional 
dimension and on candidate, potential candidate and the European 
Neighbourhood Policy countries. The EU is committed to create better 
outcomes for health through “sustained collective leadership in global health”. 
Thus, coherence between internal and external health policies, as well as the 
sharing of values, experience and expertise, is essential in attaining the EU’s 
global health goals.  EU’s new governance system  involves  “a  shift  in  
emphasis  away  from  command and-control in favour of “regulatory” 
approaches, which are less  rigid, less prescriptive, less committed to uniform 
approaches, and  less hierarchical in nature (Búrca, Scot, 2006: 2.3). According 
to the subsidiarity principles the Union has to act only “if the objectives of the 
proposed action cannot be sufficiently achieved by the Member States”. 
Subsidiarity iterates that public policies should be handled by the lowest 
(vertical subsidiarity) or closest (horizontal subsidiarity) possible level to where 
they will have their effect. Regional authorities should perform only those tasks  
which cannot be carried out effectively at a more  immediate or local level, and 
undertake only  those initiatives which exceed the capacity of  lower 
communities, individuals or private groups  acting independently (Brugnoli et 
all,  2007: 64). 
 In conclusion, EU’s action shall respect the responsibilities of the 
Member States for the definition of their health policy and for the organization 
and delivery of health services and medical care. The responsibilities of the 
Member States shall include the management of health services and medical 
care and the allocation of the resources assigned to them. Health policy is a 
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polymorphic and complex sector, a cross-cutting policy field as aspects of 
health policy are regulated in other policy sectors.  
 
 
1.3 Health in the European Union: legal framework  
 “Everyone has the right of access to preventive health care and the 
right to benefit from medical treatment under the conditions established by 
national laws and practices”. This is how the right to “Health Care” is described 
in the “Charter of Fundamental Rights of the European Union” agreed in Nice 
on 7 December 2000.  One of the tasks of the Community is “by establishing a 
common market and a monetary union to promote throughout the Community 
a harmonious, balanced and sustainable development of economic activities, a 
high level of social protection, the raising of the standard of living and quality 
of life and social cohesion and solidarity among Member States” (art. 2 of the 
Treaty of Amsterdam). According to Article 3 of the EC Treaty, the European 
Community has a broad policy mandate for health (“the activities of the 
Community shall include… a contribution to the attainment of a high level of 
health protection...”) including specific tasks which are set out in Article 152.  
Member States health systems comprise many components all of which form 
sub-markets which are subject to Treaty provisions governing the free 
movement of goods and services. These include the market for medical 
manpower and the markets for pharmaceuticals, medical devices and 
production of healthcare services. 
 
 
1.4 Member States under allocation and mediation 
 The state’s role has moved from “authoritative allocation and mediation 
above to the role of partner and mediator” (Krohler – Koch, 1996: 371) 
regarding health issues. The recent Reform Treaty (agreed in Lisbon in October 
2007) has not changed this; on the contrary, what belongs to national 
competence is now explicitly laid down in the new provision on health. 
Nevertheless, the EU has a considerable impact on health care and health law. 
First of all, the development of the internal market and the subsequent 
harmonization of law to remove obstacles to cross border traffic of goods, 
services and persons has had substantial consequences for several parts of 
health law, sometimes even marginalizing the role of national legislation. 
Secondly, EU policies in other fields such as fair competition, insurance law, 
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and consumer protection continue to have their own side-effects on the health 
policies. Finally, there is the potentially far reaching influence of the European 
Court of Justice, with its sometimes revolutionary application of the free 
movement principles of the EU Treaty to the health care sector. 
 Health issues were found as derogations for the Member States in 
relation to the free movement principle in the old Article 36 and Article 46 EC. 
The Treaty of Maastricht1 (1992) introduced a new Article 129 EC (renumbered 
Article 152 EC after the Treaty of Amsterdam 1997) setting out the limited 
competence of the then Community to regulate the area of public health. 
Essentially the involvement of the EU was to complement the activities of the 
Member States, encouraging and promoting the coordination and cooperation 
between the Member States on issues which may have a cross-border effect. 
The former Article 152(5) EC stated that any action by the Community in the 
field of public health should fully respect the responsibilities of the Member 
States for the organization and delivery of health services and medical care.  
Following Maastricht, the Commission moved quickly to develop EU public 
health policy. Examples included: a 1991–93 action programme against AIDS, 
the 1992 European drug prevention week and the 1993 public health action 
programme (COM (93) 559) that focused on eight main areas - cancer, drug 
dependence, AIDS, health promotion, health monitoring and research, 
pollution-related diseases, injury prevention and rare diseases. In general, by the 
mid-1990s, EU public health policy issue areas in almost every DG in the 
Commission (Abel-Smith et al., 1995: 127). 
 Article 168(7) TFEU (The Consolidated Version of the Treaty of the 
Functioning of the European Union), which is now in place since the Treaty of 
Lisbon 2009, also acknowledges these responsibilities, although in different 
wording. The Protocol [9] on Services of General Interest annexed to the TEU 
and TFEU by the Treaty of Lisbon 2009 emphasizes, in Article 2, that the 
Treaties do not in any way affect the competence of the Member States to 
provide, commission and organize non-economic services of general interest. 
The role of health care as a national responsibility in what Ferrara (Ferrara, 
2005) has termed a “bounded space” with defined membership and territorial 
                                                          
1
 The Treaty of Amsterdam 1997 raised the profile of public health issues by adding it 
to the list of activities of the Community in Article 3(1) (p) EC. The new Article 152 
EC also mainstreamed a “high level of human health protection” through Community 
policies. 
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scope has been challenged. The limited EU competence to legislate in the field 
of health care was lost in the use of the fundamental free movement provisions 
to create a new citizenship right to travel abroad for health care and have the 
costs reimbursed by the State of affiliation. Above that a process of “EU 
competence creep” (Van De Gronden, Szyszczak, Neergaard, Krajewski,             
2011: 484) into the national health care systems is taking place. In 2002, the 
health action programme was developed and passed that consolidated earlier 
health actions and allocated €312 million to a new 2003–08 EU Public Health 
Action Programme (Decision No. 1786/2002/EC). The subsequent 2007 
Commission White Paper, Together for Health: A Strategic Approach for the EU 
2008–2013 (COM (2007) 630 final) and the second health action programme 
(2008–13) (Decision No 1350/2007/EC) was similar to the first with only a 
slight rise in overall funding to €321 million, averaging just over €50 million a 
year for public health policy for the entire EU. 
 The proposed Constitution for Europe promises to extend the health 
competency further, offering a EU competency in public health shared with 
member states and justified by the real problems of controlling infectious 
diseases and public health risks at the member state level. Article 13.2 creates a 
shared competence in “common safety concerns in public health matters” 
(shared competencies, it appears, will not put ceilings on EU activity but will 
allow state activity). Article 16.1 establishes the European competency for 
“supporting, coordinating, or complementary” action over “protection and 
improvement of human health.”, but in practice Member States have shown 
little desire for EU involvement in their health services (Jorens, 2002; 
Hatzopoulos, 2002: 106). 
 The “EU competence creep” raises the question of a constitutional 
nature: how is at the present stage of the European integration process a 
balance struck between the EU and national health care powers. Resolving this 
question starts with pointing out that incrementally, the European Court of 
Justice of the European Union (ECJ) is seen as the central Institutional actor 
exercising considerable influence on the health care systems of the Member 
States. The ECJ has repeatedly stated as “a mantra” that the responsibility over 
the organization and delivery of health care services is the responsibility of the 
Member States (seen in ECJ, Case 238/82, Duphar [1984] ECR 523). In an 
increasingly complex environment, health has become the business not only of 
health ministries but of a vast range of stakeholders including purchasers of 
health services, professional organizations, educational institutions, donors, 
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industry, advocacy groups, citizens and users of health services. Governments 
are becoming increasingly aware of the importance of broad public 
participation in policy-making and the demand for duly considering public 
values, priorities and concerns. Good governance for health enhances the 
performance of health systems by improving transparency and accountability. 
Informing policies and programmes through evidence on the performance of 
health systems and the effects of implemented action are key instruments of 
good governance Health 2010 (Draft – WHO, Regional Office for Europe, 
2011: 86). 
 EU Member States have chosen different ways to organize their health 
systems reflecting different social and economic backgrounds as well as health 
policy goals. Different policy instruments are used for health systems 
integration hard law or soft law. (Greer, 2008), but there is value in 
collaborating, sharing experience and information EU Member States explicitly 
stated that equitable, effective and high quality healthcare systems are a means 
of promoting both economic growth and social cohesion in the EU. The nature 
of the policy instruments (binding/ non-binding decisions) is modified by using 
soft law in particular. The growing use of soft law has been widely identified as 
a way of steering without coercion, leaving broad ranges of autonomy to EU 
institutional actors, member states and private actors with regard to the 
implementation of measures and to their individual adjustment to common 
objectives. (Diedrichs; Reiners; Wessels, 2011: 24). 
 According to Stoker (1998) national governance could be described 
with five broad characteristics:  
1. It refers to a complex set of institutions and actors that are drawn from 
but also  beyond government;  
2. It recognizes the blurring of boundaries and responsibilities for tackling 
social and  economic issues;  
3.  It identifies the power dependence involved in the relationships between  
institutions involved in collective action;  
4.  It is about autonomous self-governing networks of actors;  
5.  It recognizes the capacity to get things done which does not rest on the 
power of government to command or use its authority. It sees 
government as able to use new tools and techniques to steer and guide. 
 EU Member States health systems have evolved individually over a long 
period of time and are based on very different organisational patterns and 
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principles. According to the OECD classification heath systems are referred to 
as Bismarckian where they involve social insurance and third party payers 
providing reimbursement insurance (Luxembourg, France, Belgium) or 
benefits-in-kind (Germany, Netherlands); or as Beveridge systems where 
funding is predominantly through taxation (Central and Eastern Europe).  
 Health is an good example of the interconnected policy-making 
required in the 21st century, not only because of the need to address the health 
determinants but also because it is clearly a so-called “wicked problem” 
(Kickbusch; Bucket, 2010: 16-18). Health policy is characterised by an explicit 
concern for health and equity in all areas of policy and by accountability for 
health impact. The main aim of healthy public policy is to create a supportive 
environment to enable people to lead healthy lives. The European Union, is 
facing a particularly complex governance challenge, has made explicit its notion 
of good governance in general terms. In the health arena the EU has being 
accumulating a number of “genetic” and “developmental” difficulties: an 
artificial distinction between “public health” and the other components of the 
health system, an ambitious treaty obligation to assess the impact on health of 
other policies with very limited practical application this far, a European Court 
of Justice driven policy on patient mobility. The political sensitivity of EU 
institutions might explain why the EU is taking a less than active role in 
contributing to monitoring and evaluation of health governance. (Kickbusch, 
Bucket 2010) The roots to considering the health aspects of the Community 
policies go back to the 1950s, when occupational health and safety were put on 
the agenda of the European Coal and Steel Community. 
 Governance in the European Union is “multi-level”, in the sense of 
involving interactions between sub-national, national, EU, and transnational 
institutions and actors.  The EU’s constitution operates in a “top-down” mode, 
with distinct spheres of competence between EU institutions and those of the 
Member States and regional or local actors. According to Flinders (2002), the 
notion of governance refers to the challenge to take on the direction and 
coordination of a complex ensemble of organizations through a control system 
built upon many links. The key elements for good governance could be 
presented as follows: (Louise St-Pierre, 2005:14). 
 The inclusion of several actors from both inside and outside the 
government;  
 The use of horizontal and vertical management;  
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 Accountability and control mechanisms; 
 High-level political commitment;  
 Financial and human resources support;  
  Skills development;  
  The existence of knowledge production systems. 
 
 
2. Europeanisation of Health Policies 
 
2.1 Institutionalization of policy styles 
 Academics have focused increasing attention on the nature of European 
institutions and their impact on those of Member States, they to tend to 
disagree over whether the EU is a collection of unitary states (Taylor, 1991; 
Moravscik, 1991; Garrett, 1992), or as a quasi-federal state (Sbragia, 1993: 28; 
Schmidt, 1997; Kohler-Koch, 2005). Europeanisation will be defined as: 
Processes of (a) construction, (b) diffusion, and (c) institutionalization of 
formal and informal rules, procedures, policy paradigms, styles, ‘ways of doing 
things’, and shared beliefs and norms which are first defined and consolidated 
in the making of EU public policy and politics and then incorporated in the 
logic of domestic discourse, identities, political structures, and public policies. 
(Radaelli, 2003: 30). 
 By exploring the Europeanisation of health policy I follow the 
assumption that the system of governance in the EU serves as an institutional 
setting to maintain governmental autonomy regarding societal actors, including 
the control over which other actors will be granted access in given functional 
contexts, there would obviously be limitations to more horizontal modes of 
governance in the EU. Under the conditions of globalisation and growing 
economic interdependence, Member States lose their problem-solving capacity, 
which they try to redress, on a higher level of aggregation, by establishing new 
forms of joint governance in the form of integrated policy-making structures. 
Healthcare integration is characterized by a fragmented degree of coerciveness. 
 As a field of integration, healthcare is institutionalized in a scattered 
way, in the sense that it lacks the binding knots of political commitments. 
However, it is a field of integration which demonstrates the powerful role of 
law in transcending high spirited, but inconcrete, principles, such as the free 
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movement of services and Union citizenship, into effective tools of 
governance. (Martisen, 2008: 171). 
 Europeanisation has developed many facets (Olsen, 2002/2003) and 
has been used to explain a confusing range of heterogeneous phenomena and 
processes of change (Radaelli, 2000). Despite a possible risk of “conceptual 
stretching” (Sartori, 1970) The case under study illustrates at least four 
(interrelated) perspectives of the Europeanisation of health policy, that is, 
Europeanisation: (1) as supranational institution building; (2) as affecting 
domestic politics, polities, and public policies, and as such changing domestic 
opportunity structures; 3) as a dynamic intertwining of top-down and bottom-
up processes including two tiered games, feedback loops, and unintended 
outcomes; and finally, (4) as a diffusion of European policy paradigms and 
integration requirements throughout national policy debates and arenas by 
shaping problem perceptions and framing policy solutions. European 
integration is characterized by a fundamental asymmetry which can be 
described as a dualism between supranational European law and 
intergovernmental European policy-making.  
 Health policy is a dazzling and complex policy sector: it is a service 
sector (personal services, and health professionals, service providers, 
purchasers) It is a highly regulated market for goods (pharmaceuticals, 
remedies, medical equipment). It is a cross-cutting policy sector, health-policy 
aspects are part of and regulated in a multitude of policy sectors, such as 
environmental policy, consumer,  protection, industrial safety standards, and 
EU single market policy. Compared to other welfare-state and social policies, 
health policy has traditionally more “market traces” (Lamping; Steffen, 2004). 
Given the fact that health policy and health care is an intrinsic and considerable 
part of the European market of goods and services, it is not surprising that 
large parts of it have been affected by European policy-making: single market 
compatibility, coordination, and harmonisation. Although it is clear that the 
national health care systems are not immune for EU law, the Europeanisation 
process, which these systems are subject to, have a sophisticated nature: as the 
famous Echternach procession two steps forwards are followed by one step 
backwards. (Gronde; Szyszczak, 2011: 448). How can Member States shape 
national health care systems in a way that they could ensure the proper 
reception of the EU rules on free movement, procurement, harmonisation, 
competition and European citizenship? In other words how should the second 
pillar of governance (EU law) be placed on the first pillar of governance 
Cristinela-Ionela VELICU 
 
182 
 
(national health care system)? First, the competent national authorities must 
base their interventions on strong and logic (“consistent”) causal links between 
the measures to be taken (such as planning) and the objectives to be attained 
(such as universal coverage). Europeanisation of health policy it is “chaordic,” a 
term borrowed from Hock (Hock, 2000) denoting a combination of chaos and 
order. The Europeanisation of health policy, this particular combination of 
chaos and order results from at least three factors: the existence of both 
national and European authority over various aspects of the health policy field; 
particular characteristics of the health sector; and rather ambiguous treaty 
provisions. 
 Regarding the treaty, Hervey (Hervey, 2007: 1) concludes that, at first 
glance, there is “nothing [that] would touch national health policies or their 
fundamental values and principles” (Martinsen, 2005: 1036), argues that health 
policy is the “less likely policy field” for discussing Europeanisation effects. 
Greer analyzes the EU impact on national health-care systems as “uninvited 
Europeanisation” (Greer, 2006). He identifies specific “critical junctures” 
(Greer, 2008) for the development of EU policies in the health-care sector. 
Treaties provide the EU with only restricted responsibilities and competencies 
in marginal areas of health policy, member states have exclusive policy rights: 
Article 152 of the Treaty Establishing the European Community (TEC) and the 
Treaty of Lisbon concede that “European Union action in the field of public 
health shall fully respect the responsibilities of the member states for the 
organization and delivery of health services and medical care” (TEC, Art. 152 
No. 5 and Treaty of Lisbon, Art. 152 No. 7). Direct influence of the EU on 
financing and delivery of medical care, that is, on the core of the national 
“health-care states” (Moran, 1999), has thus been formally excluded from the 
policy mandate of the EU. There are, however, explicit exceptions: cross-
border social security rules are under the competence of the EU (TEC, Art. 42), 
and Article 3 of the TEC raises the protection of health to the rank of a 
Community objective. The EU Charter of Fundamental Rights states that 
“everyone has the right of access to preventive healthcare and the right to 
benefit from medical treatment.” The EU also has to perform specific tasks 
foreseen by Article 152 of the TEC (and extended by the Treaty of Lisbon) in 
the broad field of public health. Furthermore, the European Court of Justice 
(ECJ) confirmed on several occasions that health systems are part of the “single 
market.”  The internal market regime is therefore basically applicable to them, 
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although Member States try to keep the EU out of social policy and particularly 
to protect their health policy competency. Finally, the Commission has clarified 
the issue as follows: “Respecting national responsibility for health systems does 
not mean doing nothing at European level” (Communication of the 
Commission (COM) 2004/301:16). 
 The Treaty explicitly introduces monitoring and evaluation approach as 
an integral part of health policy emphasizing the need for systematic collection 
and analysis of information on processes and impact of public health actions. 
Having a more robust legislative basis will enable the European Commission, in 
close contact with the Member States, to promote initiatives aiming at the 
establishment of guidelines and indicators, the organization of exchange of best 
practice, and the preparation of the necessary elements for periodic monitoring 
and evaluation. Collaboration between European countries in activities aimed 
at: 
 fostering elaboration of common indicators for assessing outputs and 
outcomes; 
 establishment of frameworks for systematic 
 reviewing needs; and regular monitoring of activities and periodic 
evaluations of outcomes in areas of health promotion and prevention and 
control of diseases. 
 Achieving a whole-of-government approach to intersectoral working 
requires more than a simple mandate. Evidence indicates clearly that 
institutional mechanisms are required. A clear shared strategic societal narrative 
on health is needed, with the objectives of embedding health and health equity 
into the main government strategies and financial mechanisms; stimulating 
debates in parliament and in cabinet committees and the mass media; and 
ensuring clear and multiple-stakeholder mechanisms for accountability. The 
available possibilities here include arms-length independent bodies, formal 
consultative groups and making documents and decision-making processes and 
outcomes widely available for debate. (Health 2020, 2010) National health 
ministries coordinate different types of activities as part of their health system 
stewardship capacity: they define a vision for health, and strategy and policies to 
achieve better health; they exert influence across all sectors of government and 
advocate for better health; they ensure good governance supporting the 
achievement of health system goals; they ensure the alignment of the health 
system design with goals pursued; they make use of legal, regulatory and policy 
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instruments to steer health system performance; and they collect, disseminate 
and apply appropriate health information and research evidence. (WHO, 2000) 
 The Europeanisation process in this policy field is direct and mainly 
crisis driven in the area of public health, where the EU now holds a clear 
mandate and is actively engaged in institution building, with DG SANCO as a 
key player.  It is indirect and mainly law driven in the area of healthcare and 
services, where most of the EU interventions borrow legitimacy from other 
policy fields and mandates, mainly from the four freedoms (for the circulation 
of goods, services, capital and labour within the European Union) and the 
European competition regime, with the Commission and the ECJ as leading 
actors. It is politically driven in the newly Europeanised areas of health 
expenditure, coverage, and access, where the OMC (Open Method of 
Coordination) is sought to constitute a forum and procedure of cooperation 
and coordination. It is also politically driven, but under the leadership of 
professionals and scientific expertise, in sensitive areas with important national 
differences and trans-sectoral implications, such as bioethical policy. During the 
European Council of Lisbon, in March 2000, OMC was introduced in the 
context of the long-term aim to develop the knowledge-based economy, in 
tandem with increased social cohesion and employment, both qualitatively and 
quantitatively (Council of the European Union, 2000: 4) The OMC it is a post-
regulatory approach to governance, in which there is a preference for 
procedures or general standards with wide margins for variation, rather than 
detailed and non-flexible rules and legislation. 
 EU Treaties which are the definitive statements on the scope of 
European law state explicitly that health care is a responsibility for Member 
States. Thus, health systems involve interactions with people (staff and 
patients), goods (pharmaceuticals and devices) and services (health care funders 
and providers), all of whose freedom to move across borders is guaranteed by 
the same Treaty, it is increasingly apparent that many of their activities are 
subject to European law. The European Union (EU) has both economic and 
social goals and, since the Treaty of Maastricht, it has been required to 
“contribute to the attainment of a high level of health protection”. 
 In order to resolve this apparent puzzle, it is necessary to examine the 
underlying constellation of interests among governments represented in the 
Council of Ministers? Unanimous or qualified-majority voting rules 
institutionalize veto positions - and it is analytically true that, ceteris paribus, the 
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existence of multiple veto positions reduces the capacity for political action 
(Tsebelis, 1995) The Europeanisation process is thus developing as an                 
issue-specific, fragmented, and incremental process, necessarily technocratic 
and patchy, but quite consistent. Some authors are more sensitive to the 
fragmented aspects of the process or to the absence of explicit policy decisions. 
Daly insists on “what seem at best loosely connected fields” (Daly, 2007: 1), 
while others, such as Ferrera, stress out the constant process of “incremental 
social supra-nationalism” (Ferrera, 2005: 239). 
 Article 152 of the TEC specifies that actions in the public health area 
should contribute toward ensuring a “high level of health protection 
throughout the Union” by preventing human illness and disease, eliminating 
sources of danger to health, and ensuring that all European policies are 
compatible with health protection (Hervey, 2002). Since the mid-1990s, the 
Commission has promoted an EU-wide dialogue on health issues. In May 2000, 
it proposed a new health strategy based on the “Programme of Community 
Action in the Field of Public Health,” including a precise schedule covering 
first the period 2001–2006 and then, in a renewed plan, the period of           
2003–2008. The expansion of powers and provisions has often been a               
crisis-driven and haphazard process of competence accumulation at the 
Community level. In this process, the Commission, particularly the restructured 
DG “Health and Consumer Protection” (DG Sanco), has provided political 
leadership. Outbreaks of communicable diseases, like AIDS (Steffen, 2004), 
CJD, SARS, and BSE1 (Krapohl, 2004; Vincent, 2004), and other potential 
threats to public health on a European scale, including “bioterrorism” (COM 
2003/320), opened up temporary windows of opportunity. They gave the 
Commission the chance to actively organize cooperation among Member 
States, which eventually allowed it to further centralize competencies and to 
establish intervention capacities at the EU level. The cross-cutting nature of 
public health issues provides room for the “treaty based game” (Rhodes, 1995). 
According to Rhodes (1995) “treaty base game” describes the process of 
transferring topics and borrowing legitimization from other treaties, as 
illustrated by the avian flu case, when public health legislation (2005/94/EC) 
was based on the EU common agricultural policy. 
 The establishment of a comprehensive EU-wide regulatory framework 
for the collection, manufacture, and supply of blood, plasma, and blood 
products has become a significant part of growing EU competence and 
influence in public health governance. Health policy is a striking example of the 
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Commission’s capacity to turn “constraint into opportunity by becoming a 
“network” organization, working with and through public and private bodies 
within the member states and at EU level” (Laffan, 2002: 123). 
 
 
2.2 Health without borders: Health in all policies?  
 The EU Health Strategy adopted in 2007 “Together for Health: A 
Strategic Approach for the EU 2008-2013” sets out the EU principles for 
global health policy. The principles include recognizing the links between health 
and economic prosperity, taking a value-driven approach, integrating health in 
all policies, and strengthening the EU’s voice in global health. The need for a 
new approach to health governance in 21st century that builds on intersectoral 
action and health in all policies. Health-in-all-policies is a horizontal, 
complementary policy-related strategy with a high potential to contributing to 
population health. The core of health in all policies is to examine determinants 
of health, which can be influenced to improve health but are mainly controlled 
by policies of sectors other than health.  This concept clearly builds on the first 
two waves of collaborative approaches highlighted in primary health care and 
health promotion, drawing on their strengths and learning from their 
shortcomings. It is an innovative policy strategy that responds to the critical 
role that health plays in the economies and social life of 21st century societies in 
ways that take it beyond intersectoral action and healthy public policy. 
Horizontal health governance has become a dynamic and partnership-based 
policy process that is no longer driven only by the health sector but by a larger 
agenda that includes the contribution by health to other sectors. (WHO: 1997) 
HIAP is a concept that already underpins work on health at the European level. 
Under article 168 of the Treaty, the EU is required to make sure that “a high 
level of health protection [is] ensured in the definition and implementation of 
all Policies and Activities of the Union”. Health-in-all-policies (HIAP) 
approaches will be further encouraged and promoted at all levels, including 
through giving Member States new opportunities to network, share experience 
and best practice, with the aim of supporting increased intersectoral 
cooperation in the field of health. The use of HIA (Health Impact assessment) 
and HSIA (Health Systems Impact Assessment), is already recognised as part of 
the Commission’s Impact Assessment mechanism also in reference to 
encourage health-in-all-policies in third countries. Health impact assessment 
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merits particular attention in this section dealing with governance tools, because 
it is considered one of the most structured approaches to integrate health in all 
policies (HiAP) (Lock, 2000; Sim, Mackie, 2003) The health impact is “a 
combination of procedures, methods and tools by which a policy, program  or 
project may be judged as to its potential effects on the health of a population, 
and the  distribution of those effects within the population” (WHO European 
Centre for Health Policy, 1999) in other words can be considered a governance 
tool, since it fosters interaction between public administration sectors and 
encourages “boundary works” (Bekker, 2007). 
 Important examples of the whole-of-government approach for health in 
all policies in Europe can be found in England, Finland, France, the 
Netherlands, Norway and Sweden. These countries use combinations of 
governance tools such as policy formulation, target setting, public health laws, 
cabinet level coordination, interdepartmental committees, horizontal and 
vertical coordination mechanisms, public hearings, cross-departmental spending 
reviews and new forms of intelligence provision in a relatively coherent 
government framework. A study showed (WHO, 2005) that 40 out of the 52 
WHO European Region Member States had formulated HFA-style policies by 
2004. Although the organisation and delivery of health services remains 
primarily a responsibility of the Member States, the EU also has a range of 
responsibilities in the field of global health. The EU’s role is to complement 
national policies although in some specific areas it has explicit authority to 
legislate (early warning and response to communicable diseases, quality and 
safety of substances of human origin, organs, blood and blood derivatives, food 
and product safety, veterinary and plant health measures directly aimed at 
public health). The European Commission has a Treaty obligation in Article 
168 to “foster cooperation with third countries and the competent international 
organisations in the sphere of public health”. 
 Healthcare is viewed as a as part of the services provided in the 
(national) general interest, and is a public good. (Ostrom, 1990) Free 
movement, competition and public procurement law are the main areas which 
invite clashes between national health care policies and EU law, but the 
potential range is even wider, touching upon citizenship and discrimination 
issues, human rights and data protection. Health policy in the European Union 
raises important arguments: first, is the self-interest of the 27 Member States: 
for the EU to exercise a wider role in health policy would require a new Treaty 
provision. It would necessarily be one that recognised public health as a 
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multidimensional concept – both in theory and practice – rather than a “low” 
policy field, limiting it only to tackling specific diseases and “taking health into 
account in other Community policies” (Mosalios, 2001: 21) On other hand, the 
duality or competence-sharing between the EU and Member States where 
health policy is concerned is captured in the understanding of European law as 
supranational and European policy-making as intergovernmental. 
 
 
3. Health Market a Double Dynamic? 
 
 Health is not a typical market and health care systems carry in 
themselves economic as well as social elements.  The importance of health to 
the individual, and the need for Member States to ensure equitable access to 
health care across their populations, gives rise to a form of market which is not 
easily subject to the competitive model.  The internal market shall comprise an 
area in which the free movement of persons, services, goods and capital shall be 
assured in accordance with the Constitution (Article III - 14). 
  Health care is considered an economic activity (transaction against 
remuneration) falling under the scope of free movement. The specific nature of 
(statutory) health care does not remove it from this ambit. The free movement 
and competition requirements of the internal European market may sometimes 
conflict with national interests around these high-employment and           
export-orientated industries, and around the setting of prices and 
reimbursement rates for social security schemes. Consequently, case studies by 
Permanand and Mossialos (2005) and Kotzian (2002) show a complex picture. 
This deadlock “stem[s] primarily from a dissonance between the principle of 
subsidiarity, which enables national governments to determine healthcare 
policy, and the free movement goals of the single market, under which 
medicines are treated as an industrial good” (Permanand; Mossialos, 2005: 49). 
The creation of the single market has a dual role in the development of an EU 
health policy framework. First, as it enables the Community to regulate only in 
areas such as: patient movement across borders within the EU, the 
establishment of a system for the mutual recognition of professional 
qualifications or pricing, reimbursement of pharmaceuticals and voluntary 
health insurance. Second, the European single market has served as an 
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important magnet securing intergovernmental agreement on the economic 
aspects associated with health policy in Europe.  
 According to European Union’s legislation patient mobility and               
cross-border healthcare cover both the situation in which a patient purchases 
such medicinal products and medical devices in a Member State of affiliation 
and the situation in which the patient purchases such medicinal products and 
medical devices in another Member State than that in which the prescription 
was issued (Directive 2011/24/EU). Even if Member States have sought to 
limit cross-border usage in order to limit its potential for health tourism 
(Hervey, 1998: 147–150) patients have Treaty-based rights to a treatment 
anywhere in the EU, funded by the home member state if the treatment would 
have been funded at home by the member state of residence and the 
reimbursement of medical costs.  
 Member States retain responsibility for providing safe, high quality, 
efficient and quantitatively adequate healthcare to citizens on their territory. 
Furthermore, the transposition of the European directives into national 
legislation and its application should not result in patients being encouraged to 
receive treatment outside their Member State of affiliation. The obligation of 
reimbursement of cross-border healthcare, it is limited to healthcare to which 
the insured person is entitled according to the legislation of the Member State 
of affiliation. The right to reimbursement of the costs of healthcare provided in 
another Member State by the statutory social security system of patients as 
insured persons has been recognised by the Court of Justice in several rulings. 
For example, the Kohll and Decker cases2 created a second avenue of                 
cross-border health care in addition to Regulation 1408/71, patients could from 
then on seek medical treatment in another Member State at will, rather than at 
the discretion of their domestic insurance institutions.  Discussion about access 
to health care abroad has traditionally been based on the principle of free 
movement of people within the EU, but in 1998 the ECJ was required to assess 
the rules regarding access to health care abroad in the light of the free 
movement of goods and services. In refusing to reimburse Kohll and Decker 
for the treatment received abroad, the Luxembourg government had relied 
                                                          
2 The Kohll and Decker rulings of the ECJ concerned two persons insured under the 
Luxembourg social security system who had obtained orthodontic treatment in 
Germany (Raymond Kohll) and spectacles in Belgium (Nicolas Decker) and wanted to 
be reimbursed by their health insurance fund in Luxembourg, even though the fund 
had not previously authorised their treatment abroad (135), (136). (EC Treaty). 
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upon the national rules incorporating EC Regulation 1408/71 into 
Luxembourg law. The Kohll and Decker rulings established clearly, for the first 
time, that the economic rules regarding the free movement of goods and 
services within the EU can be applied to social security systems. 
 Under the Lisbon process3 newer forms of governance have emerged. 
Like the Single Market Programme these were linked to a deadline and an 
objective but unlike that programme, the governance methods, captured under 
the umbrella term “the open method of coordination” (OMC) were primarily 
based on policy learning, reporting and the issuance of guidelines all firmly 
within the realm of soft law which may or may not result in binding legal 
measures. 
 Post regulatory approach, the open method of coordination, is applied 
in health policy only very carefully and gradually from 2004 onward, the OMC 
has above all enabled the Commission to switch from “aggressive leadership” 
(Wendon, 1998: 59), unlikely to work in the health sector, to a softer and 
somewhat ideational political leadership. This type of political leadership has in 
any case been developing generally, as Borras (2009) argues, since the reform of 
the Lisbon strategy in 2005. The OMC strategy helps the Commission to 
circumvent many of the obstacles to supranational regulation of the health-care 
sector identified in this article. These obstacles range from weak official 
legitimacy, a vague policy mandate, and lack of political consensus (Member 
State interest in own health policy), to weaknesses in policy coherence and 
policy formulation resulting from the intergovernmental system of negotiation 
as well as the internal structure of the health policy sector. 
 The main objective in health policy field is enhancing the governance of 
health systems to improve accountability and performance (Health                     
2020, Draft – WHO, Regional Office for Europe, 2011), therefore, the Health 
2020 programme sets up strategic orientations: 
                                                          
3 The objective articulated by the European Council in Lisbon in 2000 was to make 
Europe the most competitive and dynamic knowledge-based economy in the world, 
capable of sustaining economic growth with more and better jobs and greater social 
cohesion with a deadline of 2010. This has now been reduced to growth and jobs and 
the deadline has been dropped, generally EC Commission, Delivering on Growth and Jobs: 
A New and Integrated Economic and Employment Co-ordination Cycle in the EU, SEC(2005) 
193, 3 February 2005. 
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 Working together for health and wellbeing in the European                 
Region – Member States, international strategic partners, public  health 
constituencies; 
 Committing to a whole-of-government approach for health and  
wellbeing; 
 Strengthening leadership for health and wellbeing and ensuring  that all 
sectors understand and act on their responsibility for health; 
 Upholding the right to health and a value-based approach to  action for 
health and wellbeing; 
 Tackling the health divide between and within countries; 
 Investing in governance for health and wellbeing that reflects  the realities 
and needs of the 21st century; 
 Investing in solutions that work and are appropriate for  Member States 
in different circumstances, to address the public  health challenges of the 
European Region; 
 Integrating strong evidence-based economic arguments to  advocate for 
and support action on disease prevention and  inequalities;  
 Mobilizing action at country, inter-country and European levels for 
tackling the chronic diseases epidemic; 
 Preparing and dealing effectively with emergencies; 
 Ensuring high-performing, outcome-oriented and transparent health 
systems. 
 Since the late 1990s, DG Sanco4 has shown determination in agenda 
setting and problem framing, and in confronting governments with elaborate 
policy proposals. Success depends on DG Sanco’s ability to build supra- and 
transnational supporting coalitions in order to increase both its legitimacy and 
its political influence. 
 Regarding the Europeanisation of public health single market I my 
argue about a double dynamic. First, a positive integration - the Member States 
harmonisation of secondary legislation (Directive 36/2005 on the recognition 
of professional qualifications; Regulation 883/04 on the coordination of social 
security systems; Third non-life insurance Directive 49/92; Transparency 
                                                          
4 Health benefited from a two-fold shift of competences within the Commission: the 
transfer of competence for food from the Agriculture and Fisheries Directorate to the 
Directorate for Health and Consumer Protection, and the internal reorganization of 
the latter. 
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Directive 89/105 on the pricing and reimbursement of medicinal products), 
and second, a negative integration by the direct application of Treaty rules. 
Positive integration requires the introduction of an active, supranational policy. 
Typically, the EU has negotiated a policy template, and the task is to put it into 
operation in the Member States (Radaelli, 2003). The Commission has to ensure 
that legislation is properly implemented, and it can refer governments to the 
ECJ if necessary, thus the supremacy of European law is indicator of the 
hierarchical nature of arrangements. By contrast with positive integration, 
negative integration relates to sectors where the removal of national barriers 
suffices to create a common policy. 
 The four freedoms and the single market competition law (negative 
integration) define the conditions for market access and market functioning and 
aim at abolishing legal prohibitions against national regulations that might 
function as barriers to the free movement, or as distortions of competition 
between Member States within the EU. According to Threlfall’s (2003) concept 
of “single social areas”, citizens can experience the EU as if it was a single 
country. In this “single healthcare area”, national welfare-state frontiers are 
increasingly becoming  legally insignificant for national citizens and making way 
to new European social citizenship boundaries. The EU is on the way to 
become one “Europe of Patients” (DGV, 1999: 1) or, “Europe of Health”5, 
although one not politically created.  
 
 
4. Conclusion  
 
 This paper argued that the health governance it is as a contested 
mechanism of coordination, therefore we acknowledged a double discrepancy: 
economic policies and single market regulations are now decided at the 
European level when social policies are still formally decided at the national 
one; economic policies are now based on a neo-classical, supply-side approach 
when national social policies and programmes are still linked with demand-side 
approach. The contradictory picture is related to the existence of national and 
EU competency over different domains of the health policy field. This paper 
identifies a growing European health policy compound characterized by new, 
                                                          
5 Byrne, Commissioner for Health and Consumer Protection, at the European Health 
Forum, Bad  Gastein, 3 October 2003 (SPEECH/03/443). 
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complex, and often overlapping responsibilities between the national and 
supranational levels. It conceptualizes the Europeanisation of health policy as a 
differential, multiple, but accidental process. The evolution of modes of 
governance in the health sector reveals a complex and multifaceted picture 
characterized by overall systemic dynamics. Summing up, the impact of major 
Treaty reforms and European recommendations in the healthcare field affect 
the European Union on its legal and living architecture. It is also clear that 
there are not two distinct processes at work here, but that domestic health law 
influences European health governance and that European health governance 
influences domestic health law. Even though European healthcare systems still 
formally appear to be national, European integration has reduced the policy 
margin Member States can effectively use when regulating their healthcare 
sector. Up to now the integration of health policies in the EU policy framework 
has been a juristic process (negative integration) and Member States remain 
hesitant to actively shape European health policies.  
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